Poxvirus vectors encoding HIV antigens, and methods of use thereof
U.S. patent number 11,229,693 [Application Number 16/620,669] was granted by the patent office on 2022-01-25 for poxvirus vectors encoding hiv antigens, and methods of use thereof. This patent grant is currently assigned to Bavarian Nordic A/S, Janssen Vaccines & Prevention B.V.. The grantee listed for this patent is Bavarian Nordic A/S, Janssen Vaccines & Prevention B.V.. Invention is credited to Viki Bockstal, Jerome Hubertina Henricus Victor Custers, Markus Kalla, Johannes Petrus Maria Langedijk, Frank Wegmann.
https://uspto.report/patent/grant/11,229,693
https://www.dailymail.co.uk/health/article-10832623/UK-stockpiling-thousands-monkeypox-vaccines-drugs-UK-cases-rise-nine.html
They are truly evil.